Detalhe da pesquisa
1.
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Hepatology
; 2024 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38478755
2.
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.
Hepatology
; 78(1): 195-211, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36924031
3.
Thy-1 restricts steatosis and liver fibrosis in steatotic liver disease.
Liver Int
; 2024 May 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38702958
4.
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis.
Liver Int
; 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38573034
5.
Confirmation of guideline-defined hepatitis C screening strategies within the 'Check-Up35+' examination in the primary care setting.
Liver Int
; 43(4): 785-793, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36621849
6.
Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis.
Z Gastroenterol
; 61(11): 1500-1503, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36736346
7.
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.
Gut
; 71(5): 1006-1019, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34001645
8.
Age Dependence of Liver Enzymes: An Analysis of Over 1,300,000 Consecutive Blood Samples.
Clin Gastroenterol Hepatol
; 20(3): 641-650, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33524594
9.
Letter to the Editor: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis.
Hepatology
; 79(5): E136-E137, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38150002
10.
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs.
Liver Int
; 40(3): 539-548, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31241820
11.
Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).
Scand J Gastroenterol
; 55(6): 706-711, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32476514
12.
Transitioning FIB-4 Score: From Fibrosis Screening Tool to Key Biomarker for Clinical Endpoints.
J Hepatol
; 2024 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38777260
13.
Laboratory reform counteracts the WHO hepatitis C elimination strategy in Germany.
J Viral Hepat
; 26(12): 1493-1495, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31386783
14.
Contrast-enhanced ultrasound characteristics for the diagnosis of biliary adenofibroma.
Ultraschall Med
; 45(1): 84-86, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38081210
15.
16.
Budget impact analysis on the introduction of a guideline based hepatitis B and C screening into a routine check-up in the German primary care setting.
Scand J Gastroenterol
; 53(1): 76-82, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-29065740
17.
Predictive value of liver and spleen stiffness in advanced alcoholic cirrhosis with refractory ascites.
Z Gastroenterol
; 56(6): 561-568, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29890557
18.
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.
J Hepatol
; 66(5): 1022-1030, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28039099
19.
Reply.
Clin Gastroenterol Hepatol
; 20(3): 716-717, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33823292
20.
Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease.
J Transl Med
; 15(1): 106, 2017 05 19.
Artigo
Inglês
| MEDLINE | ID: mdl-28521774